Scott Durbin

Scott joined Viveve in early 2013 and became Chief Executive Officer and Director in May 2018.  He previously served as the company’s Chief Financial Officer and has been instrumental in the company’s growth.  He is committed to leading the company and the clinical and commercial development of its innovative CMRF technology to solidify its position as a global leader in women’s intimate health.  Scott’s 25 year career in the life sciences industry covers corporate finance, strategy, clinical, and operational experience. Prior to joining Viveve, he was Chief Financial Officer of Aastrom Biosciences, a publicly traded, cardiovascular cell therapy company. Before Aastrom, he spent six years as Chief Operating and Financial Officer for Prescient Medical,Inc. (PMI), a privately held company that developed diagnostic imaging catheters and coronary stents designed to reduce deaths from heart attacks. Prior to PMI, he spent several years as a financial consultant for two publicly traded biotech companies, Scios, Inc. – a Johnson & Johnson company and Alteon, Inc. He began his career in corporate finance as an investment banker in the healthcare and M&A groups at Lehman Brothers Inc., where he focused on mergers and acquisitions and financings for the life science industry. At Lehman, he successfully executed over $5 billion in transactions for medical device and biotech companies. He began his career as a Director of Neurophysiology for Biotronic, Inc.

Scott received a B.S. from the University of Michigan and an M.P.H. in Health Management with Honors from the Yale University School of Medicine and School of Management.

James Atkinson

Prior to joining Viveve as Chief Business Officer and President, Jim was the Senior Vice President of Global Sales at Ulthera, Inc. through April, 2014. He was the third employee to join the company in October, 2006 as Senior Vice President of Sales and Marketing. While at Ulthera, he helped grow the company from 3 to 165 employees and established a global distribution network that included 42 distributors, covering 52 countries. Ulthera was purchased by Merz Aesthetics for $600 million in 2014. Before joining Ulthera, Mr. Atkinson served as Vice President of Sales and Marketing for the Cardiac Surgery Division at St. Jude Medical, where his responsibilities included launching the Biocor stented tissue valve, recognized as the fastest growing heart valve brand in the industry. Prior to St. Jude Medical, he served as Vice President of Sales for Medtronic Vascular, a $200 million division of Medtronic, Inc. Mr. Atkinson's entrepreneurial spirit led him to co-found and serve as Vice President of Sales and Business Development for Medical Simulation Corporation, the leading developer of state-of-the-art simulation technologies and services for the cardiology, cardiac surgery and nursing industries. His career began as a sales representative at Ethicon Endosurgery where he progressed through positions of increasing responsibility to Regional Manager.

Suzon Lommel

Suzon Lommel has more than 30 years of experience in the medical device industry developing regulatory and quality systems.  She currently serves as the Senior Vice President of Regulatory and Quality Affairs at Viveve. Prior to joining Viveve, she was Global Vice President of Regulatory and Quality Affairs at Ulthera, Inc. which was acquired by Merz Aesthetics in July, 2014. Additional prior experience includes executive and senior management roles at Breathe Technologies, Inc., Foxhollow Technologies, Inc., Advanced Stent Technology, and Boston Scientific. Suzon has extensive experience with the U.S. Food and Drug Administration and international regulatory agencies.  She has authored numerous 510k, IDE, PMA, and international submissions. Ms. Lommel holds a degree in Physics from Moorpark College.

Jim Maffezzoli

Jim Maffezzoli joined Viveve in March 2018 as Senior Vice President of Global Marketing. Most recently Jim served as the Vice President of Marketing at Allergan (AGN) where he was responsible for building the Women's Health therapeutic portfolio in the U.S. to a $1.1B enterprise achieving +17% growth. He spearheaded the successful launches of numerous new products and partnered with business development in evaluating multiple licensing and acquisition opportunities.

Prior to Allergan, Jim served as the Global Head of Marketing at Exeltis USA, Inc., a Division of the Grupo Insud, where he built the Women's Health and Dermatology businesses through internal product development, licensing and acquisitions, geographic expansion, and improved in-country sales effectiveness. He contributed to 40% growth over a three-year period at Exeltis and established a global marketing group, integrated a digital marketing strategy, and a Customer Relationship Management platform. Jim's senior management career includes ten years with Pfizer Inc. (PFE) where he served on marketing leadership teams for urology and women's health, and as Early Commercial Lead to build the global product pipeline. He was responsible for the consumer strategy and advertising group where he drove enhancements across a multitude of brands. He has recorded success in consumer marketing from his position as Director of New Products, Consumer Medicines Division for Bristol-Myers Squibb (BMY), and his nine-year tenure with Kraft/Nabisco (now Mondelez International, Inc. [MDLZ]) where he led brand teams in three different business units.

Over the last 20 years he has successfully driven growth and created value in diverse businesses through the application of strategic planning, innovative brand building, product pipeline development / lifecycle management, business development, and cross functional leadership in multiple industries and therapeutic areas.

Jim holds a M.B.A. from the J.L Kellogg Graduate School of Management at Northwestern University, and a B.A. in Political Economy from Princeton University. He also serves as Chairman of the Board of Trustees for the Metropolitan Montessori School in New York City.

Debbie Wilkerson, Ph.D.

Debbie joined Viveve in 2015 and was promoted to Vice President of Clinical Affairs in August, 2016. She brings over 17 years of experience in life sciences including pharmaceutical, biologics, medical devices and women's reproductive health. She has extensive clinical affairs leadership experience across multiple therapeutic areas as well as experience in operations and regulatory affairs. Debbie has launched many U.S. and international trials in women's health, immunology, urology, orthopedics and dermatology. In connection with this work she has published numerous articles in peer-reviewed publications.

Prior to joining Viveve, Debbie served as the Director of Clinical Research for Medtronic Spine and Biologics (MDT), Medtronic's second largest business, and managed a high profile biologic. She was Executive Director of Clinical Operations at OV Clinical Trials in Colorado and Director of Research and Development at Alita Pharmaceuticals. As an Associate Director and then Director of Clinical Operations at Duramed Research, Inc., a subsidiary of Barr Pharmaceuticals, Debbie focused on women's health programs, including bringing Plan B emergency contraception OTC. Previous to these executive management roles, she was Director of Scientific Affairs at Women's Capital Corporation responsible for operations, safety, FDA submissions, marketing and external collaboration, which was preceded by her role as Research Associate at The David and Lucile Packard Foundation.

Debbie received her Bachelor of Science in Chemistry degree from the University of Michigan and earned her Doctorate in Biochemistry from the Stanford University School of Medicine.

Jim Robbins

Jim joined Viveve as Vice President of Finance in July 2014 and was promoted to Vice President of Finance and Administration in May 2017.  In May 2018, Jim assumed expanded responsibilities and was appointed as the Company’s Principal Accounting Officer. He has over twenty years of accounting and finance experience in both industry and public accounting. Prior to joining Viveve, Jim provided accounting, finance and business consulting services for various biotech companies. From 2010 to 2012 he served as Vice President of Finance and Administration for Auxogyn, Inc., a privately held medical technology company focused on advancing women’s reproductive health by translating scientific discoveries in early embryo development into clinical solutions that improve patient outcomes in vitro fertilization (IVF) procedures. He served as Director of Finance and Vice President of Finance 2004 to 2010 for Micrus Endovascular, Inc., a company which develops, manufactures and markets both implantable and disposable medical devices used in the treatment of cerebral vascular diseases. Prior to Micrus Endovascular, Jim served at Genitope Corporation as Corporate Controller, a biotechnology company focused on the research and development of novel immunotherapies for the treatment of cancer. From 1995 to 2001, he served in management positions for high technology companies including Extricity, Inc., InVision Technologies, Inc., and Truevision, Inc. Jim was in the audit practice of Price Waterhouse, LLP from 1987 to 1995.

He received his Bachelor of Business Administration with a concentration in accounting from the University of Texas at Austin and is a Certified Public Accountant.

Marty Kerber

Marty joined Viveve, Inc. in January of 2018 as the new Vice President of Operations, bringing a wealth of experience from the medical device field. As a General Manager, Chief Operating Officer and Senior Vice President at multiple device companies, his comprehensive expertise spans engineering, manufacturing operations, managing contract manufacturers, product development, plant engineering, process development, new product launches, Lean/Six Sigma processes, supply chain and customer service.

As COO, Chief Engineer and later the Vice President Corporate Engineering at inSleep Health, Marty created the manufacturing organization and drove the commercialization of the innovative sleep disorder breathing product. In his capacity as the General Manager of MME Group, Inc., he took the organization from tool making to a contract manufacturing company that created highly regulated customer products for Fortune 500 medical companies. As Vice President of Engineering at Covidien, Ltd. he realigned the organization in preparation for separation from Tyco (TYC) and created the Advanced Manufacturing Engineering function in support of an increase of $50 million in NPI spending. He holds seven patents and three certifications.

Marty received his B.S. degree in Engineering Mechanics from the U.S. Air Force Academy, an M.S. degree in Materials Engineering from the University of Alabama, and a MBA in Production and Operations Management from the University of Colorado.

He grew up on a small family farm with 10 siblings and considers himself a small-town boy at heart who chased his dreams to make the world a better place.

Sean Shapiro

Sean joined Viveve as Vice President of U.S. Sales in September, 2016 and brings extensive experience in medical device and aesthetic industry sales, commercial team organization, development, and management. Most recently, Sean served as Director of Sales, Merz North America, Aesthetic Device Division where he was responsible for capital and consumable sales of $100M annually directing a team of 50 regional and direct sales professionals. He led the commercial launch of the Cellfina™ System that in 12 months became the market leader generating over $15M in sales. A Regional Sales Director at Ulthera, Inc., Sean managed a team selling new ultrasound tissue lifting technology and capital equipment to physicians in the aesthetic marketplace earning top sales awards personally and with the team he led. At Zeltiq, Inc. he served as an Area Sales Manager and launched CoolSculpting®, again earning sales revenue and management awards. Prior to this, Sean had five years as a successful Area Sales Manager at Lumenis, Inc.

A known and respected sales leader in the aesthetic marketplace, Sean has consistently received annual awards and recognition for top sales dollar volume, region and territory revenue, new technology and product launches in addition to sales management and business development accomplishments.

Sean earned his Bachelor of Science in Communications from the University of Arizona.

Lori McMillan

Lori has over 20 years of leadership experience in human resources and strategic talent management in healthcare and technology industries. Prior to joining Viveve in May 2017, she was Vice President of Talent Management and Chief Administrative Officer at The Breakaway Group, a Colorado-based business that develops simulation education of HIT applications for over 1 million healthcare provider end users. Lori has held senior leadership positions demonstrating success in creating and implementing effective human capital and operational strategies in support of organizations’ mission, values and goals.   She served as a human resources executive at the Association of periOperative Registered Nurses (AORN) and Evolving Systems, Inc., a software company which tripled in size prior to their IPO.  Early in her career, Lori held management and sales executive positions in the cosmetics and fragrance industries with Estee Lauder and Riviera Concepts. She received her Bachelor of Arts degree in Sociology at Colorado State University and completed HR executive and business education programs at Stanford University and Vassar College.